Developing novel treatments for mood disorders: accelerating discovery

The Corticosteroid Receptor Hypothesis of Depression

2000 • 2,126 citations

A Molecular and Cellular Theory of Depression

1997 • 2,091 citations

Neuroimaging studies of mood disorders

2000 • 1,303 citations

Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

1998 • 1,067 citations

A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression

1999 • 1,056 citations

Complex promoter and coding region β ₂ -adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

2000 • 971 citations

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability

2000 • 937 citations

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1997 • 906 citations

Pharmacogenetics and the practice of medicine

2000 • 822 citations

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

2001 • 818 citations

DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION

1996 • 764 citations

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

2000 • 698 citations

Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation

1999 • 656 citations

Effects of SSRIs on Sexual Function

1999 • 652 citations

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1998 • 605 citations

Antidepressant-induced mania and cycle acceleration: a controversy revisited

1995 • 600 citations

Textbook of psychopharmacology

1975 • 583 citations

Neurobiology of Mental Illness

2011 • 532 citations

The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders

1999 • 498 citations

Initiation and adaptation: a paradigm for understanding psychotropic drug action

1996 • 489 citations

Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines

1997 • 446 citations

Higher Than Normal Plasma Interleukin-6 Concentrations in Cancer Patients With Depression: Preliminary Findings

2001 • 441 citations

Resistance to antidepressant medications and short-term clinical response to ECT

1996 • 427 citations

Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life Depression

2000 • 410 citations

Serotonin transporter gene polymorphism and antidepressant response

2000 • 392 citations

Phosphorylation and Sequestration of Serotonin Transporters Differentially Modulated by Psychostimulants

1999 • 387 citations

Effectiveness of St John's Wort in Major Depression

2001 • 380 citations

Neurobiology of Mental Illness.

2000 • 344 citations

Trazodone

1994 • 325 citations

The pharmacologic profile of mirtazapine.

1996 • 325 citations

Parallel Genotyping of Human SNPs Using Generic High-density Oligonucleotide Tag Arrays

2000 • 309 citations

A double-blind trial of bupropion versus desipramine for bipolar depression.

1994 • 281 citations

Rapid Reversal of Psychotic Depression Using Mifepristone

2001 • 274 citations

Regional Cerebral Blood Flow in Mood Disorders, III

1994 • 261 citations

A corticosteroid/dopamine hypothesis for psychotic depression and related states

1985 • 244 citations

Cocaine and Antidepressant-Sensitive Biogenic Amine Transporters Exist in Regulated Complexes with Protein Phosphatase 2A

2000 • 234 citations

The Anticonvulsant Hypothesis of the Mechanisms of Action of ECT

1999 • 231 citations

Reboxetine: the first selective noradrenaline re-uptake inhibitor

2000 • 211 citations

Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins

1998 • 187 citations

Complementary Therapies for Depression

1998 • 174 citations

Comparison of Bifrontal and Bitemporal ECT for Major Depression

2000 • 170 citations

The Role of Serotonin Transporter Protein Gene in Antidepressant-Induced Mania in Bipolar Disorder

2001 • 159 citations

Antidepressants: past, present and future

2000 • 150 citations

Pharmacokinetics and Safety of Duloxetine, a Dual‐Serotonin and Norepinephrine Reuptake Inhibitor

2000 • 147 citations

Regional cerebral blood flow in mood disorders

1997 • 143 citations

Therapeutic advantage of bifrontal electrode placement in ECT

1993 • 137 citations

Genotyping:The predictive power of haplotypes in clinical response

2000 • 134 citations

The use of antidepressant drugs in patients with heart disease.

1998 • 128 citations

Mirtazapine Substitution in SSRI-Induced Sexual Dysfunction

2000 • 125 citations

Neurokinin₁ Receptor Antagonists as Potential Antidepressants

2001 • 113 citations

Reemergence of Sexual Dysfunction in Patients With Major Depressive Disorder

2001 • 109 citations

Short-Term Augmentation of Fluoxetine With Clonazepam in the Treatment of Depression: A Double-Blind Study

1998 • 103 citations

A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression

1993 • 102 citations

Consent and privacy in pharmacogenetic testing

2001 • 98 citations

Neurochemical Individuality

2000 • 98 citations

Physical properties and quantification of the ECT stimulus: I. Basic principles.

1994 • 94 citations

Electrode placement in ECT: cognitive effects

1990 • 86 citations

Endogenous Anticonvulsant Substance in Rat Cerebrospinal Fluid After a Generalized Seizure

1985 • 81 citations

Venlafaxine: A novel antidepressant that has a dual mechanism of action

1996 • 80 citations

Applications of biochip and microarray systems in pharmacogenomics

2000 • 79 citations

A theory of convulsive therapy in endogenous depression: Significance of hypothalamic functions

1980 • 72 citations

A SNPshot: pharmacogenetics and the future of drug therapy

2000 • 71 citations

Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission

1997 • 71 citations

Augmentation strategies in patients with refractory depression

1996 • 70 citations

ECT seizure therapeutic adequacy.

1994 • 63 citations

Dosage, Seizure Threshold, and the Antidepressant Efficacy of Electroconvulsive Therapy

1986 • 61 citations

Paroxetine binding to the rat norepinephrine transporter in vivo

2000 • 61 citations

[Treatment of depression].

1960 • 59 citations

Diencephalic Stimulation and the Effects of Ect in Endogenous Depression

1976 • 57 citations

CYP2D6 Genotyping with Oligonucleotide Microarrays and Nortriptyline Concentrations in Geriatric Depression

2001 • 57 citations

Imaging serotonergic neurotransmission in depression: hippocampal pathophysiology may mirror global brain alterations

2000 • 50 citations

Asymmetric Bilateral Right Frontotemporal Left Frontal Stimulus Electrode Placement for Electroconvulsive Therapy

1994 • 45 citations

Glutamate—Hypothalamic-Pituitary-Adrenal Axis Interactions: Implications for Mood and Anxiety Disorders

2001 • 43 citations

Management of the depressive component of bipolar disorder

1996 • 32 citations

The serotonergic antidepressant nefazodone inhibits the serotonin transporter: In vivo and ex vivo studies

1995 • 31 citations

Yohimbine augmentation of fluvoxamine in refractory depression: A single-blind study

1995 • 31 citations

Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.

1994 • 17 citations

The effect of somatic treatment and comorbidity on immediate outcome in manic patients

1989 • 16 citations

Unilateral ECT: Medications and Monitoring

1989 • 2 citations

Positron‐Emission Tomography Tracers as Intellectual Property

2001 • 2 citations

Positron-Emission Tomography Tracers as Intellectual Property

2001 • 1 citations

Deleted Work

1955 • 0 citations